Table 1 |
||
|
Baseline Parameter Values |
||
|
Acquisition of clinical immunity |
θ-1 |
10 years |
|
Loss of clinical immunity |
γ-1 |
2 years |
|
Fraction of new infections that are treated and cleared |
ξ1 |
0.3 |
|
ξ2 |
0.01 |
|
|
Rate clinical symptoms arise (σi) times Fraction treated (fi) equals rate existing infections are cleared by drugs (ρi) |
σ1f1 = ρ1 |
0.025(0.2) = 1/200 |
|
σ2f2 = ρ2 |
0.01(0.2) = 1/500 |
|
|
Disease induced death rate |
m |
180/100000/year |
|
Human feeding rate |
α |
0.3 |
|
Infectivity rate |
b |
0.8 |
|
Mosquito death rate |
g |
1/10 |
|
Number of days required for sporogony |
n |
10 |
|
Recovery rate |
rw |
1/(165/b) |
|
rx |
rw(fitness cost) |
|
|
|
||
|
Klein et al. Malaria Journal 2008 7:67 doi:10.1186/1475-2875-7-67 |
||
